Free Shipping in the U.S. for orders over $1000. Shop Now>>
Colorectal cancer encompasses various types, including adenocarcinoma, squamous cell carcinoma, neuroendocrine tumors, and mucinous carcinoma, each with unique characteristics and implications for patient management. Techniques including Western blots, ELISA, flow cytometry, co-immunoprecipitation, and immunohistochemistry can distinguish among the different types of colorectal cancer and provide vital information about cell proliferation and disease progression, which is critical for the early detection, prognosis/monitoring, and treatment of the disease.
NeoBiotechnologies proudly offers a comprehensive selection of antibodies for colorectal cancer research (see the table below), with a particular emphasis on IHC-validated antibodies targeting colorectal cancer markers. Our antibodies are rigorously validated for specificity, ensuring precise and reliable results.